Empery Asset Management »

Scynexis shares owned by Empery Asset Management

Quarter-by-quarter ownership of Scynexis shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Scynexis

Tip: Access up to 7 years of quarterly data

All positions including Scynexis held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scynexis by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $515k 127k 4.07

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Nervgen Pharma Ord (NGEN)
Precision Biosciences Com New (DTIL)
Clene Com New (CLNN)
Annovis Bio (ANVS)
Lantern Pharma (LTRN)
Amc Entmt Hldgs Cl A New (AMC)
Tenaya Therapeutics (TNYA)
One And One Green Technologi Usd Cl A Ord Shs (YDDL)
Cyngn Inc Com Par $0 00001 (CYN)
Venu Hldg Corp (VENU)
Greenland Energy *w Exp 04/21/203
Ur-energy (URG)
Satellos Bioscience (MSLE)

View all positions for Empery Asset Management

Top funds holding Scynexis

Vanguard Capital Management
Empery Asset Management
Renaissance Technologies
Vanguard Fiduciary Trust
Wealth Effects
Dimensional Fund Advisors
Vanguard Global Advisers
Tower Research Capital
Simplex Trading
Us Bancorp
Northwestern Mutual Wealth Management Company
HighMark Wealth Management
Cornerstone Planning Group
Bogart Wealth

View all funds holding Scynexis